Influence of vehicle and anterior chamber protein concentration on cyclosporine penetration through the isolated rabbit cornea

References

• Nussenblatt R. B. The use of cyclosporin in ocular inflammatory disorders. Transplant. Proc. 1988; 20: 114–121
   PubMed Web of Science ®Google Scholar
• Liversidge J., Thomson A. W., Sewell H. F., Forrester J. V. EAU in the guinea pig: inhibition of cell-mediated immunity and Ia antigen expression by cyclosporin A. Clin. Exp. Immunol. 1987; 69: 591–600
   PubMed Web of Science ®Google Scholar
• Binder A. I., Graham E. M., Sanders M. D., Dinning W., James D. G., Denman A. M. Cyclosporin A in the treatment of Behçet's uveitis. Br. J. Rheumatol. 1987; 26: 285–291
   PubMedGoogle Scholar
• Young E., Schachter J., Prendergast R. A., Taylor H. R. The effect of cyclosporine in chlamydial eye infection. Curr. Eye Res. 1987; 6: 683–689
   PubMed Web of Science ®Google Scholar
• Kaswan R. L., Salisbury M. A., Ward D. A. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops. Arch. Ophthalmol. 1989; 107: 1210–1216
   PubMed Web of Science ®Google Scholar
• Ben Ezra D., Cohen E., Rakotomalala M., de Courten C. H., Harris W., Chajek T., Friedman G., Matamoros N. Treatment of endogenous uveitis with cyclosporin A. Transplant. Proc. 1988; 20: 122–127
   Web of Science ®Google Scholar
• Belin M. W., Bouchard C. S., Phillips T. M. Update on topical cyclosporin A: Background, immunology, and pharmacology. Cornea 1990; 2: 184–195
   Google Scholar
• Liegner J. T., Yee R. W., Wild J. H. Topical cyclosporine therapy for ulcerative keratitis associated with rheumatoid arthritis. Am. J. Ophthalmol. 1990; 109: 610–612
   PubMed Web of Science ®Google Scholar
• Guo A., Ohia E., Xu J. T., Bhattacherjee P., Kulkarni P. Effects of anti-inflammatory and immunosuppressive drugs on the heterolamellar corneal transplantation in rabbits. Curr. Eye Res. 1990; 9: 749–759
   PubMed Web of Science ®Google Scholar
• Williams K. A., Grutzmacher R. D., Roussel T. J., Coster D. J. A comparison of the effects of topical cyclosporins and topical steroid on rabbit corneal allograft rejection. Transplantation 1985; 39: 242–244
   PubMed Web of Science ®Google Scholar
• Goichot-Bonnat L., Chemla P., Pouliquen Y. Cyclosporin A collyre dans la prevention du rejet de greffe de cornee a haut risque. II. Resultats cliniques post-operatoires. J. Fr. Ophthalmol. 1987; 10: 213–217
   PubMed Web of Science ®Google Scholar
• Belin M. W., Bouchard C. S., Franz S., Chmielinska J. Topical cyclosporin in high-risk corneal transplants. Ophthalmology 1989; 96: 1144–1150
   PubMed Web of Science ®Google Scholar
• Hoffman F., Wiederholt M. Lokale Behandlung des Hornhauttransplantates beim Menschem mit Cyclosporin A. Klin. Mbl. Augenheilk. 1985; 187: 92–96
   PubMedGoogle Scholar
• Ben Ezra D., Maftzir G. Ocular penetration of cyclosporine A in the rat eye. Arch. Ophthalmol. 1990; 108: 584–587
   PubMedGoogle Scholar
• Ben Ezra D., Maftzir G. Ocular penetration of cyclosporine A. The rabbit eye. Invest. Ophthalmol. Vis. Sci. 1990; 31: 1362–1366
   PubMed Web of Science ®Google Scholar
• Wiederholt M., Kossendrup D., Schulz W., Hoffmann F. Pharmacokinetic of topical cyclosporin A in the rabbit eye. Invest. Ophthalmol. Vis. Sci. 1986; 27: 519–524
   PubMed Web of Science ®Google Scholar
• Palestine A. G., Nussenblatt R. B., Chan C. C. Cyclosporine penetration into the anterior chamber and cerebrospinal fluid. Am. J. Ophthalmol. 1985; 99: 210–211
   PubMed Web of Science ®Google Scholar
• Diaz-Llopis M., Menezo J. L. Penetration of 2% cyclosporin eyedrops into human aqueous humor. Br. J. Ophthalmol. 1989; 72: 600–603
   Google Scholar
• Ben Ezra D., Maftzir G., de Courten C., Timonen P. Ocular penetration of cyclosporine A. III. The human eye. Br. J. Ophthalmol. 1990; 74: 350–352
   PubMed Web of Science ®Google Scholar
• Mosteller M. W., Gebhardt B. M., Hamilton A. M., Kaufman H. E. Penetration of topical cyclosporine into the rabbit cornea, aqueous humor and serum. Arch. Ophthalmol. 1985; 103: 101–102
   PubMedGoogle Scholar
• Kaswan R. L. Intraocular penetration of topically applied cyclosporine. Transplant. Proc. 1988; 20: 650–655
   PubMed Web of Science ®Google Scholar
• Bell T. A.G., Hunnisett A. G. Cyclosporin A: Tissue levels following topical and systemic administration to rabbits. Br. J. Ophthalmol. 1986; 70: 852–855
   PubMed Web of Science ®Google Scholar
• Newton C., Gebhardt P. M., Kaufman H. E. Topically applied cyclosporin in azone prolongs corneal allograft survival. Invest. Ophthalmol. Vis. Sci. 1988; 29: 208–215
   PubMed Web of Science ®Google Scholar
• Duchene D., Wonessidjewe D. Pharmaceutical uses of cyclodextrins and derivatives. Drug Devel. Ind. Pharm. 1990; 16: 2487–2499
   Web of Science ®Google Scholar
• Saettone M. F., Burgalassi S., Giannaccini B. Preparation and evaluation in rabbits or topical solutions containing forskolin. J. Oc. Pharmacol. 1989; 5: 111–118
   PubMedGoogle Scholar
• Kanai A., Alba R. M., Takano T., Kobayashi C., Nakajima A., Kurihara K., Yokoyama T., Fukami M. The effect on the cornea of alpha cyclodextrin vehicle for cyclosporin eye drops. Transplant Proc. 1989; 21: 3150–3152
   PubMed Web of Science ®Google Scholar
• Alba R. M., Kanai A., Takano T., Kobayashi C., Nakajima A., Kurihara K., Fukami M. The effect on the cornea of various vehicles for cyclosporin eye drops. Folia Ophthalmol. Jpn. 1989; 40: 902–908
   Google Scholar
• Pederson J. E., Green K. Aqueous humor dynamics: Experimental studies. Exp. Eye Res. 1973; 15: 277–297
   PubMed Web of Science ®Google Scholar
• Eakins K. E. Increased intraocular pressure produced by prostaglandins E1 and E2 in the cat eye. Exp. Eye Res. 1970; 10: 87–92
   PubMed Web of Science ®Google Scholar
• Beitch B. R., Eakins K. E. The effects of prostaglandins on the intraocular pressure of the rabbit. Br. J. Pharmacol. 1969; 37: 158–167
   PubMed Web of Science ®Google Scholar
• Williams R. N., Paterson C. A. Anomalous effects of anti-inflammatory corticosteroids in endotoxin-induced ocular inflammation. Eur. J. Pharmacol. 1984; 106: 113–119
   PubMed Web of Science ®Google Scholar
• Green K., Laughter L., Hull D. S. Rabbit corneal endothelial permeability in the presence and absence of adenosine and glutathione. Curr. Eye Res. 1982–83; 2: 797–802
   PubMed Web of Science ®Google Scholar
• Green K., Chapman J. M., Cheeks L., Hull D. S. Effect of thymoxamine on corneal endothelium. Lens Eye Tox. Res. 1991; 8: 1–8
   PubMedGoogle Scholar
• Green K., Hull D. S., Vaughn E. D., Malizia A. A., Bowman K. Rabbit endothelial response to ophthalmic preservatives. Arch. Ophthalmol. 1977; 95: 2218–2221
   PubMed Web of Science ®Google Scholar
• Green K., Green M. A. Permeability to water of rabbit corneal membranes. Am. J. Physiol. 1969; 217: 635–641
   PubMed Web of Science ®Google Scholar
• Blifeld C., Ettenger R. B. Measurement of cyclosporine levels in samples obtained from peripheral sites and indwelling lines. New Eng. J. Med. 1987; 317: 509
   PubMed Web of Science ®Google Scholar
• Clinical Chemistry Task Force on Cyclosporine Monitoring. Critical issues in cyclosporine monitoring: Report of the Task Force on cyclosporine monitoring. Clin. Chem. 1987; 33: 1269–1288
   PubMed Web of Science ®Google Scholar
• Green K. The effects of preservatives on corneal permeability of drugs. Biopharmaceutics of Ocular Drug Delivery, P. Edman. CRC Press, Boca Raton, FL 1992, in press
   Google Scholar
• Green K. Principles and methods of ocular pharmacokinetic evaluation. Dermal and Ocular Toxicology: Fundamentals and Methods, D. Hobson. CRC Press, Boca Raton, FL 1991; 541–584
   Google Scholar
• Maurice D. M., Mishima S. Ocular Pharmacokinetics. Pharmacology of the Eye, M. L. Sears. Springer-Verlag, New York 1984; 19–116
   Google Scholar
• Green K., Chapman J. M. Benzalkonium chloride kinetics in young and adult albino and pigmented rabbit eyes. J. Toxicol. Cutan. Ocular Toxicol. 1986; 5: 133–142
   Web of Science ®Google Scholar
• Green K., Chapman J. M., Cheeks L., Clayton R. M., Wilson M., Zehir A. Detergent penetration into young and adult rabbit eyes: Comparative pharmacokinetics. J. Toxicol. Cutan. Ocular Toxicol. 1987; 6: 89–107
   Web of Science ®Google Scholar
• Doane M. C., Jensen A. D., Dohlman C. H. Penetration routes of topically applied eye medications. Am. J. Ophthalmol. 1978; 85: 383–386
   PubMed Web of Science ®Google Scholar
• Ahmed I., Patton T. F. Importance of the noncorneal absorption into the topical ophthalmic drug delivery. Invest. Ophthalmol. Vis. Sci. 1985; 26: 584–587
   PubMed Web of Science ®Google Scholar